All Pharmaceutical Articles
  • Do you have to own a pharmacy business to be successful?

    Greg L. Alston Pharmaceutical

    One of the most common questions I receive is, "Can I use professional business skills to improve my career as an employee, or do I have to own my own business to be successful?" That is a particularly awesome question, so let me dig right into it.

  • Drugs for anxiety, sleep linked to Alzheimer’s disease

    Dr. Denise A. Valenti Mental Healthcare

    Drugs used to modify behavior in young or middle-aged adults may have serious consequences in later life. Recent research has demonstrated that extended use of benzodiazepine drugs — commonly used for the management of anxiety and sleep dysfunction — increase the risk of developing Alzheimer's disease.

  • What’s causing the antibiotic development stagnation?

    Lauren Swan Pharmaceutical

    Antimicrobial-resistant bacteria are appearing in headlines more often as time goes by, along with the escalating need for new antibiotics to treat these bacteria. Yet only two new antibiotic treatments have been approved and released onto the market since 2008. There are currently seven new antimicrobial drugs in the FDA pipeline, but none of them will affect the bacteria for which we need them.

  • Making the most of the HCP rescheduling

    Jason Poquette Pharmaceutical

    Like me, you have probably heard enough of the moaning and groaning related to the upcoming Oct. 6 DEA rescheduling of hydrocodone-containing products (HCPs). I've certainly voiced my objection. Now it is time to face the facts. It's coming. There's no stopping it.

  • 5 simple fixes for Big Pharma

    Mike Wokasch Pharmaceutical

    While Big Pharma companies continue to have their sporadic good news and occasional success stories, collectively the industry is still struggling to reshape its business models in the evolving healthcare market. In this article, we'll explore five "fixes" pharmaceutical companies can make to increase their probability of success in the future.

  • How to energize your pharmacy career

    Greg L. Alston Pharmaceutical

    When you're trying to learn something new, as you will be during your pharmacy career, the only way it will make sense to you is if you have a way to connect to the information. If you can't figure out how the information is relevant to you, it's going to be very difficult for you to learn. Greg L. Alston looks at how he has learned over the years, not just as a pharmacist, but also as an educator and speaker.

  • Will you still have a job in pharmacy in 5 years?

    Greg L. Alston Pharmaceutical

    ​My personal mission is to help the next generation of pharmacists understand that the world has changed and teach them the skills to thrive in this new world order. The reality is this: The employment paradigm in this country has changed dramatically in one generation. And you need to understand the impact of this change.

  • Fall is on the way ... and so are seasonal allergies

    Dr. Denise A. Valenti Medical & Allied Healthcare

    It is estimated that ​approximately 40 million Americans have an indoor/outdoor nasal allergy more commonly called hay fever. For many of these sufferers, trees, grass, weed pollen and mold spores can be triggers for hay fever symptoms. And there are ​more allergens in the air in the fall, with ragweed and molds accounting for much of the increase.

  • The sky is falling: 5 challenges of hydrocodone rescheduling

    Jason Poquette Pharmaceutical

    ​It has been talked about for years. Some thought the topic was like Chicken Little crying that the sky was falling. To all such individuals I've got news for you — the sky has fallen and Chicken Little was right. Many, like me, always believed the rescheduling of hydrocodone combination products to Schedule II was inevitable, though sadly the least effective way to deal with the growing opioid overdosing epidemic.

  • New hydrogel drug delivery helps prevents transplant rejection

    Lynn Hetzler Medical & Allied Healthcare

    ​Clinicians currently use systemic immunosuppression in vascularized composite allotransplantation (VCA). While VCA can be a superior method of restoring the function and aesthetics of transplants, it can also cause significant side effects and negatively affect the quality of life for transplant patients.